- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a target name.
BioCentury | Mar 27, 2021
Translation in Brief
Lentigen’s trispecific CAR Ts; plus a bispecific antiviral COVID-19 mAb, Wild Biotech, Kancera and more
BioCentury’s roundup of translational news
BioCentury | Sep 4, 2019
Preclinical News
Preclinical Quick Takes: NIH's clinical trial practices in preclinical studies, plus Kancera and optimized base editors
BioCentury | Oct 13, 2016
Distillery Therapeutics
Therapeutics: Chemokine CX3C motif receptor 1 (CX3CR1)
BioCentury | May 21, 2015
Distillery Therapeutics
Therapeutics: Interleukin-1 (IL-1) β; IL-1 receptor; purinergic receptor P2X ligand-gated ion channel 7 (P2RX7; P2X7)
Items per page:
1 - 10 of 15